We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
BETAVANT OV (Nova Pharmaceuticals Australasia Pty Ltd)
Product name
BETAVANT OV
Date registered
Evaluation commenced
Decision date
Approval time
125 (255 working days)
Active ingredients
betamethasone, betamethasone dipropionate
Registration type
New generic medicine
Indication
[TRADENAME] Ointment is indicated for the relief of the inflammatory and pruritic manifestations of resistant or severe corticosteroid-responsive dermatoses. These include atopic eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus and psoriasis.
[TRADENAME] Ointment is also indicated for the maintenance of remission in chronic psoriasis.